Bayesian Capital Management, LP Liva Nova PLC Transaction History
Bayesian Capital Management, LP
- $788 Million
- Q4 2024
A detailed history of Bayesian Capital Management, LP transactions in Liva Nova PLC stock. As of the latest transaction made, Bayesian Capital Management, LP holds 4,700 shares of LIVN stock, worth $195,990. This represents 0.03% of its overall portfolio holdings.
Number of Shares
4,700Holding current value
$195,990% of portfolio
0.03%Shares
10 transactions
Others Institutions Holding LIVN
# of Institutions
274Shares Held
55.2MCall Options Held
140KPut Options Held
44.5K-
Black Rock Inc. New York, NY6.9MShares$288 Million0.01% of portfolio
-
Primecap Management CO Pasadena, CA4.75MShares$198 Million0.17% of portfolio
-
Israel Englander Millennium Management LLC | New York, Ny3.05MShares$127 Million0.07% of portfolio
-
Vanguard Group Inc Valley Forge, PA2.35MShares$98 Million0.0% of portfolio
-
State Street Corp Boston, MA2.1MShares$87.6 Million0.0% of portfolio
About LivaNova PLC
- Ticker LIVN
- Exchange NASDAQ
- Sector Healthcare
- Industry Medical Devices
- Shares Outstandng 53,545,700
- Market Cap $2.23B
- Description
- LivaNova PLC, a medical device company, designs, develops, manufactures, and sells therapeutic solutions worldwide. It operates through three segments: Cardiopulmonary, Neuromodulation, and Advanced Circulatory Support. The Cardiopulmonary segment develops, produces, and sells cardiopulmonary products, including oxygenators, heart-lung machines,...